Impact of Cannabis Act: Increase in cannabis disorders among pregnant women in Quebec

FHS
June 24, 2024
9:46 am

The impact of the Cannabis Act (CAC) and the COVID-19 pandemic on substance-related disorders among pregnant women in Quebec.

SOR-007 by Nanology for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 22, 2023

Freeline touts positive data for Gaucher disease therapy – Pharmaceutical Technology

Freeline’s gene therapy FLT201 introduces a transgene to produce an engineered GCase variant, the enzyme responsible for the symptoms of Gaucher disease. Credit: dizain via

May 10, 2024

Survey highlights substantial gaps in knowledge about maternal health

Most people know it isn’t safe to smoke or drink alcohol while pregnant, and most know that how well a pregnant person takes care of

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.